Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.10.16
关于董事会秘书、证券事务代表变换的通告
2021.09.29
2021年第一次暂时股东大会的执法意见书
2021.09.29
2021年第一次暂时股东大会决议通告
2021.08.27
深圳市高新投集团有限公司2021年半年度财务报表(未经审计)
2021.08.27
关于召开2021年第一次暂时股东大会的通知通告
2021.08.27
关于增添谋划规模并修订《公司章程》的通告
2021.08.27
半年报董事会决议通告
2021.08.27
2021年半年度财务报告
2021.07.24
关于对外捐赠支持抗洪抢险救灾的通告
2021.07.24
第五届董事会第十次聚会决议通告
第一页
上一页
15
16
17
18
19
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】